HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single-Cell and Bulk RNA-Sequencing Reveal Differences in Monocyte Susceptibility to Influenza A Virus Infection Between Africans and Europeans.

Abstract
There is considerable inter-individual and inter-population variability in response to viruses. The potential of monocytes to elicit type-I interferon responses has attracted attention to their role in viral infections. Here, we use single-cell RNA-sequencing to characterize the role of cellular heterogeneity in human variation of monocyte responses to influenza A virus (IAV) exposure. We show widespread inter-individual variability in the percentage of IAV-infected monocytes. Notably, individuals with high cellular susceptibility to IAV are characterized by a lower activation at basal state of an IRF/STAT-induced transcriptional network, which includes antiviral genes such as IFITM3, MX1 and OAS3. Upon IAV challenge, we find that cells escaping viral infection display increased mRNA expression of type-I interferon stimulated genes and decreased expression of ribosomal genes, relative to both infected cells and those never exposed to IAV. We also uncover a stronger resistance of CD16+ monocytes to IAV infection, together with CD16+ -specific mRNA expression of IL6 and TNF in response to IAV. Finally, using flow cytometry and bulk RNA-sequencing across 200 individuals of African and European ancestry, we observe a higher number of CD16+ monocytes and lower susceptibility to IAV infection among monocytes from individuals of African-descent. Based on these data, we hypothesize that higher basal monocyte activation, driven by environmental factors and/or weak-effect genetic variants, underlies the lower cellular susceptibility to IAV infection of individuals of African ancestry relative to those of European ancestry. Further studies are now required to investigate how such cellular differences in IAV susceptibility translate into population differences in clinical outcomes and susceptibility to severe influenza.
AuthorsMary B O'Neill, Hélène Quach, Julien Pothlichet, Yann Aquino, Aurélie Bisiaux, Nora Zidane, Matthieu Deschamps, Valentina Libri, Milena Hasan, Shen-Ying Zhang, Qian Zhang, Daniela Matuozzo, Aurélie Cobat, Laurent Abel, Jean-Laurent Casanova, Nadia Naffakh, Maxime Rotival, Lluis Quintana-Murci
JournalFrontiers in immunology (Front Immunol) Vol. 12 Pg. 768189 ( 2021) ISSN: 1664-3224 [Electronic] Switzerland
PMID34912340 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 O’Neill, Quach, Pothlichet, Aquino, Bisiaux, Zidane, Deschamps, Libri, Hasan, Zhang, Zhang, Matuozzo, Cobat, Abel, Casanova, Naffakh, Rotival and Quintana-Murci.
Chemical References
  • Cytokines
  • FCGR3A protein, human
  • FCGR3B protein, human
  • GPI-Linked Proteins
  • Receptors, IgG
Topics
  • Adult
  • Black People
  • Cytokines (physiology)
  • GPI-Linked Proteins (analysis)
  • Humans
  • Influenza A virus
  • Influenza, Human (ethnology)
  • Middle Aged
  • Monocytes (immunology, virology)
  • Receptors, IgG (analysis, genetics)
  • Ribosomes (physiology)
  • Sequence Analysis, RNA
  • Single-Cell Analysis
  • White People
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: